Immunotherapy against antibiotic-resistant bacteria: the Russian experience with an antistaphylococcal hyperimmune plasmaand immunoglobulin.
The Russian experience with the preparation and clinical application of an antitoxic antistaphylococcal hyperimmune plasma and immunoglobulin is described. The immunotherapies were developed in the late 1960s and put into widespread use in the Soviet Union for the prophylaxis and treatment of sepsis, pneumonia, and other conditions caused by an epidemic of antibiotic-resistant Staphylococcus aureus.
Kelly
J
J
Coates & Jarratt, Inc., 4455 Connecticut Avenue, A500, Washington, DC 20008, USA.
D000818:Animals; D000992:Antitoxins / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D006801:Humans; D007106:Immune Sera / Q000008:administration & dosage; D007116:Immunization, Passive / Q000009:adverse effects; D011817:Rabbits; D012426:Russia; D013203:Staphylococcal Infections / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D013208:Staphylococcal Toxoid / Q000276:immunology*; D013211:Staphylococcus aureus / Q000187:drug effects / Q000276:immunology*; D014611:Vaccination
D000992:Antitoxins; D007106:Immune Sera; D013208:Staphylococcal Toxoid